Mologen AG Receives Patent for Cell Based Gene Therapy

Berlin, November 3, 2008 - The Berlin biotech company MOLOGEN AG announced today that the Russian patent office is going to issue the patent for cell based gene therapy against cancer.

MORE ON THIS TOPIC